DrugPatentWatch Database Preview
Email this page to a colleagueSee Plans and Pricing
« Back to Dashboard
Hemady is a drug marketed by Dexcel Pharma and is included in one NDA.
The generic ingredient in HEMADY is dexamethasone. There are thirty-nine drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the dexamethasone profile page.
A generic version of HEMADY was approved as dexamethasone by XSPIRE PHARMA on April 28th, 1983.
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Dexcel Pharma||HEMADY||dexamethasone||TABLET;ORAL||211379-001||Oct 3, 2019||RX||Yes||Yes||Start Trial||Start Trial||Start Trial|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|